[HTML][HTML] Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE)
…, M Rubio-Rivas, A Argibay, A Marín-Ballvé… - Autoimmunity …, 2022 - Elsevier
Aim Patients with systemic sclerosis (SSc) are at increased risk of cancer, a growing cause
of non–SSc-related death among these patients. We analyzed the increased cancer risk …
of non–SSc-related death among these patients. We analyzed the increased cancer risk …
Left ventricular diastolic dysfunction in systemic sclerosis: clinical, immunological and survival differences in the Spanish RESCLE registry
Objectives: Left ventricular diastolic dysfunction (LVDD) remains poorly studied in Systemic
Sclerosis (SSc). To determine the prevalence and to define factors associated with LVDD …
Sclerosis (SSc). To determine the prevalence and to define factors associated with LVDD …
Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry
…, M Rodriguez-Carballeira, A Marin-Ballvé… - Seminars in arthritis and …, 2016 - Elsevier
Objective Digital ulcers (DU) are the most common vascular complication of systemic sclerosis
(SSc). We compared the characteristics between patients with prior or current DU with …
(SSc). We compared the characteristics between patients with prior or current DU with …
First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study
…, M Rodríguez-Carballeira, A Marín-Ballvé… - Clinical …, 2018 - Springer
The objective of the study is to determine the importance of the mode of onset as prognostic
factor in systemic sclerosis (SSc). Data were collected from the Spanish Scleroderma …
factor in systemic sclerosis (SSc). Data were collected from the Spanish Scleroderma …
Hepatobiliary involvement in systemic sclerosis and the cutaneous subsets: Characteristics and survival of patients from the Spanish RESCLE Registry
…, MR Carballeira, A Marín-Ballvé… - Seminars in Arthritis and …, 2018 - Elsevier
Objective To assess the prevalence and causes of hepatobiliary involvement (HBI) in systemic
sclerosis (SSc), to investigate the clinical characteristics and prognosis of SSc patients …
sclerosis (SSc), to investigate the clinical characteristics and prognosis of SSc patients …
Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort
…, M Rodríguez-Carballeira, A Marín-Ballvé… - Autoimmunity …, 2017 - Elsevier
Objectives According to the existence of subclinical organ involvement pre-scleroderma
should be divided into two subsets: very early and early disease. Pre-scleroderma patients …
should be divided into two subsets: very early and early disease. Pre-scleroderma patients …
Efficacy and safety of anakinra plus standard of care for patients with severe COVID-19: a randomized phase 2/3 clinical trial
P Fanlo, B del Carmelo Gracia-Tello… - JAMA Network …, 2023 - jamanetwork.com
Importance COVID-19 pneumonia is often associated with hyperinflammation. The efficacy
and safety of anakinra in treating patients with severe COVID-19 pneumonia and …
and safety of anakinra in treating patients with severe COVID-19 pneumonia and …
Longterm efficacy and safety of monotherapy versus combination therapy in systemic sclerosis–associated pulmonary arterial hypertension: A retrospective rescle …
…, M Rodríguez-Carballeira, A Marín-Ballvé… - The Journal of …, 2020 - jrheum.org
Objective. Monotherapy is an option as first-line therapy for pulmonary arterial hypertension
(PAH). However, combination therapy is a beneficial alternative. Our objective was to …
(PAH). However, combination therapy is a beneficial alternative. Our objective was to …
Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort …
M Rubio-Rivas, X Corbella, A Guillén-del-Castillo… - Autoimmunity …, 2020 - Elsevier
A few scores predicting the short-term risk of mortality in Systemic sclerosis (SSc) have been
reported to date. Our study aimed to create a predictive 15-year all-cause mortality score at …
reported to date. Our study aimed to create a predictive 15-year all-cause mortality score at …
[PDF][PDF] Serodiscordant patients with systemic sclerosis: when antibody does not correspond to skin involvement
NI Arandia, G Espinosa, CT Vilella… - Clin Exp …, 2020 - clinexprheumatol.org
Objective. Diffuse cutaneous systemic sclerosis (dcSSc) is associated with anti-topoisomerase
(ATA) whereas limited cutaneous (lcSSc) and sine scleroderma (ssSSc) are mainly …
(ATA) whereas limited cutaneous (lcSSc) and sine scleroderma (ssSSc) are mainly …